These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35688970)

  • 21. Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.
    Hendricks WPD; Zismann V; Sivaprakasam K; Legendre C; Poorman K; Tembe W; Perdigones N; Kiefer J; Liang W; DeLuca V; Stark M; Ruhe A; Froman R; Duesbery NS; Washington M; Aldrich J; Neff MW; Huentelman MJ; Hayward N; Brown K; Thamm D; Post G; Khanna C; Davis B; Breen M; Sekulic A; Trent JM
    PLoS Genet; 2018 Sep; 14(9):e1007589. PubMed ID: 30188888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
    Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
    Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Platform Omics Analysis for Identification of Molecular Characteristics and Therapeutic Targets of Uveal Melanoma.
    Kim YJ; Park SJ; Maeng KJ; Lee SC; Lee CS
    Sci Rep; 2019 Dec; 9(1):19235. PubMed ID: 31848373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma.
    Yaman B; Akalin T; Kandiloğlu G
    Am J Dermatopathol; 2015 May; 37(5):389-97. PubMed ID: 25357015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct genomic features in a retrospective cohort of mucosal, acral, and vulvovaginal melanomas.
    Shi K; Zhang B; Kong BY; Zhang Y; Igartua C; Mohan LS; Quan VL; Panah E; Isales MC; Beaubier N; Taxter TJ; White KP; Zou L; Gerami P
    J Am Acad Dermatol; 2023 May; 88(5):1051-1059. PubMed ID: 31306728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
    Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
    Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alterations in primary melanoma in Taiwan.
    Sheen YS; Tan KT; Tse KP; Liao YH; Lin MH; Chen JS; Liau JY; Tseng YJ; Lee CH; Hong CH; Liao JB; Chang HT; Chu CY
    Br J Dermatol; 2020 May; 182(5):1205-1213. PubMed ID: 31408190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
    Wang M; Banik I; Shain AH; Yeh I; Bastian BC
    Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.
    Lasota J; Kowalik A; Felisiak-Golabek A; Zięba S; Waloszczyk P; Masiuk M; Wejman J; Szumilo J; Miettinen M
    Mod Pathol; 2019 Jul; 32(7):957-966. PubMed ID: 30760858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
    Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
    Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
    Colombino M; Paliogiannis P; Pagliarello C; Cossu A; Lissia A; Satta R; Mazzoni L; Magi S; Sini MC; Manca A; Casula M; Doneddu V; Palmieri G; Stanganelli I
    Eur J Dermatol; 2018 Apr; 28(2):149-156. PubMed ID: 29180316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites.
    Sekine S; Nakanishi Y; Ogawa R; Kouda S; Kanai Y
    Virchows Arch; 2009 May; 454(5):513-7. PubMed ID: 19319568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma.
    Guan J; Gupta R; Filipp FV
    Sci Rep; 2015 Jan; 5():7857. PubMed ID: 25600636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.
    Colombino M; Capone M; Lissia A; Cossu A; Rubino C; De Giorgi V; Massi D; Fonsatti E; Staibano S; Nappi O; Pagani E; Casula M; Manca A; Sini M; Franco R; Botti G; Caracò C; Mozzillo N; Ascierto PA; Palmieri G
    J Clin Oncol; 2012 Jul; 30(20):2522-9. PubMed ID: 22614978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome landscapes of major melanoma subtypes.
    Hayward NK; Wilmott JS; Waddell N; Johansson PA; Field MA; Nones K; Patch AM; Kakavand H; Alexandrov LB; Burke H; Jakrot V; Kazakoff S; Holmes O; Leonard C; Sabarinathan R; Mularoni L; Wood S; Xu Q; Waddell N; Tembe V; Pupo GM; De Paoli-Iseppi R; Vilain RE; Shang P; Lau LMS; Dagg RA; Schramm SJ; Pritchard A; Dutton-Regester K; Newell F; Fitzgerald A; Shang CA; Grimmond SM; Pickett HA; Yang JY; Stretch JR; Behren A; Kefford RF; Hersey P; Long GV; Cebon J; Shackleton M; Spillane AJ; Saw RPM; López-Bigas N; Pearson JV; Thompson JF; Scolyer RA; Mann GJ
    Nature; 2017 May; 545(7653):175-180. PubMed ID: 28467829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.
    Edmunds SC; Cree IA; Dí Nícolantonío F; Hungerford JL; Hurren JS; Kelsell DP
    Br J Cancer; 2003 May; 88(9):1403-5. PubMed ID: 12778069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.
    Wu S; Kuo H; Li WQ; Canales AL; Han J; Qureshi AA
    Cancer Causes Control; 2014 Oct; 25(10):1379-86. PubMed ID: 25048604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.
    Egberts F; Bergner I; Krüger S; Haag J; Behrens HM; Hauschild A; Röcken C
    Ann Oncol; 2014 Jan; 25(1):246-50. PubMed ID: 24276025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.